angiography [CTA/MRA]). For US reports, internal carotid artery systolic and diastolic velocities and velocity ratios were assessed and matched for laterality to supplement accuracy. All studies with abnormal findings and a random sample of studies with normal findings were manually reviewed for confirmation. Sensitivity, positive predictive value (PPV), and prevalence were calculated.
Objective: Management of significant carotid stenosis in those with symptomatic coronary disease remains controversial. Staged and combined carotid endarterectomy (CEA) with coronary artery bypass (CAB) has been described. Yet, understanding of the additive risks of these approaches is poor. This study sought to assess outcomes in patients with clinically relevant coronary disease undergoing either isolated CEA (ICEA) or combined CEA and CAB (CCAB).
Methods: All CEAs in the Vascular Quality Initiative from 2003 to 2017 were reviewed. CCABs were identified, as were ICEAs, in patients with unrevascularized stable angina, unstable angina, or myocardial infarction (MI) within 6 months of operation. CCABs were compared with ICEAs as well as with a risk-matched cohort of ICEAs. Primary outcomes included 30-day stroke, death, and MI and these as composite (SDM). Univariate analysis and logistic regression were performed.
Results: There were 4042 patients identified, including 2582 ICEAs (64%) and 1460 CCABs (36%); 61% were male, 91% were white, and 39% had symptomatic carotid disease. Overall, stroke was 1.9%; death, 1.8%; and SDM, 4.9%. ICEAs had higher rates of postoperative MI (1.9% vs 0.9%; P ¼ .01) but lower rates of stroke (1.5% vs 2.7%; P ¼ .01), death (1% vs 3%; P < .001), and SDM (4.1% vs 6.4%; P ¼ .001). After regression, predictors of SDM were congestive heart failure (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.3-2.5; P < .001), urgent operation (OR, 1.4; 95% CI, 1.01-2.0; P ¼ .04), and CCAB (OR, 1.4; 95% CI, 1.1-1.9; P ¼ .02). After propensity matching, ICEAs continued to have higher rates of perioperative MI (2.6% vs 1.0%; P ¼ .01) and lower rates of death (1% vs 3%; P ¼ .001). However, there were no longer differences in stroke (2% vs 2.8%; P ¼ .21) or SDM (5.2% vs 6.7%; P ¼ .15). Within the matched cohort, predictors of SDM included chronic obstructive pulmonary disease (OR, 1.7; 95% CI, 1.2-2.5; P ¼ .01), congestive heart failure (OR, 1.6; 95% CI, 1.05-2.4; P ¼ .03), and symptomatic carotid disease (OR, 1.5; 95% CI, 1.04-2.2; P ¼ .03). CCAB was not significant (OR, 1.3; 95% CI, 0.9-1.9; P ¼ .14).
Conclusions: In patients with unrevascularized, clinically relevant coronary disease, CCAB reduces operative MI but increases risk of stroke and death. After risk adjustment, MI remains higher in ICEA, but differences in 30-day stroke and SDM between ICEA and CCAB are no longer appreciated. These data suggest that CCAB is not inferior to staged risk of ICEA followed by coronary revascularization. Objective: Frailty confers increased risk for morbidity and mortality after operative intervention. Intervention for carotid stenosis is associated with its share of risks. The aim of this study was to assess the impact of frailty on outcomes after carotid inventions, including both carotid endarterectomy (CEA) and carotid artery stenting (CAS).
Methods: We performed an 8-year (2005-2012) retrospective analysis of the National Surgical Quality Improvement Program including patients who underwent CEA or CAS for carotid artery stenosis. A modified frailty index was calculated. Frail status was defined as a modified frailty index $0.27. Outcome measures were inpatient complications, mortality, failure to rescue, hospital length of stay, and 30-day readmissions. Multivariate regression analysis was performed.
Results: There were 37,875 patients included, with mean age 74.9 6 6.3 years; 95.7% had CEA, whereas 4.3% had CAS. Of these patients, 27.3% were frail; 11.7% of patients had complications, 2.2% died, and 6.7% were readmitted after discharge. Frail patients had higher complication rate (23.5% vs 7.2%; P < .001), higher mortality (5.2% vs 1.1%; P ¼ .02), higher failure to rescue (12.1% vs 4.7%; P ¼ .02), longer hospital length of stay (3 [2-3] vs 1 [1-2] days; P ¼ .02), and higher 30-day readmission rate (14.9% vs 3.7%; P ¼ .03) compared with the nonfrail.
On regression analysis after controlling for age, sex, albumin level, type of surgery, and American Society of Anesthesiologists class, frail status was an independent predictor of complications, mortality, failure to rescue, and 30-day readmissions (Table) . On subanalysis of patients undergoing CAS, there was no association between frail status and complications (odds ratio Objective: Device-specific data on the long-term efficacy of endovascular aneurysm repair (EVAR) are limited by the constant evolution of stent graft design. The Zenith bifurcated stent graft (Cook Medical, Bloomington, Ind) is the only one currently in use not to have undergone major 
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